Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03360006
Title A Study Evaluating the Safety and Pharmacokinetics of ABBV-744 in Subjects With Advanced Prostate Cancer (CRPC) and Relapsed/Refractory Acute Myeloid Leukemia (AML) Cancer
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors AbbVie
Indications

acute myeloid leukemia

prostate cancer

Therapies

ABBV-744

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.